FTXH
First Trust Nasdaq Pharmaceuticals ETF
1W: +1.2%
1M: -4.5%
3M: +1.4%
YTD: +2.1%
1Y: +21.5%
3Y: +38.3%
5Y: +39.4%
$33.81
-0.01 (-0.02%)
After Hours: $33.87 (+0.05, +0.16%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$29M
Holdings51
Top 10 Wt—%
Beta0.67
% Profitable59%
Coverage0%
Portfolio Valuation
P/E27.7
P/B2.3
P/S4.2
EV/EBITDA16.9
P/FCF26.5
PEG1.61
Profitability & Returns
Gross Margin57.9%
Net Margin13.9%
ROE12.0%
ROA5.6%
ROIC9.1%
Div Yield0.86%
Leverage & Liquidity
Debt/Equity0.34
Debt/Assets0.18
Net Debt/EBITDA0.2x
Interest Cov9.3x
Current Ratio1.63
Quick Ratio1.35
Growth (YoY)
Revenue+28.3%
Net Income+40.1%
EPS+41.9%
FCF+29.0%
EBITDA+47.4%
Rev CAGR 3Y+30.1%
Quality Scores
Piotroski F5.8
Altman Z8.12
IS Quality64.3
IS Overall57.2
IS Value45.5
Median P/E16.7
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 50 | 0.0% | 5.9 |
| Other | 1 | 0.0% | — |
Smart Money Overlap
7 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| ILMN | Illumina, Inc. | 0.00% | 4 | Bullish | 12 | 1 | -1.6% |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 4 | Bullish | 16 | 1 | -4.2% |
| BIIB | Biogen Inc. | 0.00% | 4 | Bullish | 1 | 1 | -3.2% |
| CAH | Cardinal Health, Inc. | 0.00% | 4 | Bullish | 1 | 1 | -1.0% |
| PFE | Pfizer Inc. | 0.00% | 4 | Bullish | 11 | 1 | +2.8% |
| JNJ | Johnson & Johnson | 0.00% | 4 | Bullish | 12 | 2 | -0.9% |
| MRK | Merck & Co., Inc. | 0.00% | 4 | Bullish | 11 | 2 | +0.9% |
Showing 50 of 51 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Mirum Pharmaceuticals, Inc. | MIRM | 0.00% | $143,882 | 1,586 | -193.7 | $4.5B | Healthcare |
| 2 | Madrigal Pharmaceuticals, Inc. | MDGL | 0.00% | $122,185 | 269 | -35.9 | $10.6B | Healthcare |
| 3 | BridgeBio Pharma, Inc. | BBIO | 0.00% | $158,709 | 2,265 | -19.4 | $13.9B | Healthcare |
| 4 | Neurocrine Biosciences, Inc. | NBIX | 0.00% | $174,057 | 1,342 | 27.3 | $13.2B | Healthcare |
| 5 | Ionis Pharmaceuticals, Inc. | IONS | 0.00% | $196,344 | 2,753 | -30.9 | $12.0B | Healthcare |
| 6 | Amneal Pharmaceuticals, Inc. | AMRX | 0.00% | $198,514 | 16,087 | 53.3 | $3.9B | Healthcare |
| 7 | Protagonist Therapeutics, Inc. | PTGX | 0.00% | $202,140 | 1,988 | -51.0 | $6.7B | Healthcare |
| 8 | Krystal Biotech, Inc. | KRYS | 0.00% | $205,368 | 796 | 36.0 | $7.5B | Healthcare |
| 9 | Halozyme Therapeutics, Inc. | HALO | 0.00% | $207,526 | 3,280 | 23.5 | $7.5B | Healthcare |
| 10 | Alkermes Plc | ALKS | 0.00% | $206,752 | 7,280 | 20.0 | $4.9B | Healthcare |
| 11 | Medpace Holdings, Inc. | MEDP | 0.00% | $265,490 | 576 | 29.3 | $13.2B | Healthcare |
| 12 | BioMarin Pharmaceutical Inc. | BMRN | 0.00% | $277,076 | 5,035 | 30.6 | $10.7B | Healthcare |
| 13 | Arrowhead Pharmaceuticals, Inc. | ARWR | 0.00% | $303,312 | 5,325 | 42.1 | $8.5B | Healthcare |
| 14 | Guardant Health, Inc. | GH | 0.00% | $154,821 | 1,738 | -26.8 | $11.4B | Healthcare |
| 15 | Elanco Animal Health Incorporated | ELAN | 0.00% | $335,302 | 13,348 | -54.6 | $12.7B | Healthcare |
| 16 | Exelixis, Inc. | EXEL | 0.00% | $354,300 | 8,587 | 14.8 | $11.5B | Healthcare |
| 17 | Incyte Corporation | INCY | 0.00% | $405,076 | 4,358 | 14.2 | $18.4B | Healthcare |
| 18 | PTC Therapeutics, Inc. | PTCT | 0.00% | $412,981 | 6,157 | 7.9 | $5.5B | Healthcare |
| 19 | Illumina, Inc. | ILMN | 0.00% | $543,831 | 4,296 | 22.7 | $19.3B | Healthcare |
| 20 | Zoetis Inc. | ZTS | 0.00% | $639,105 | 5,510 | 19.1 | $51.4B | Healthcare |
| 21 | Jazz Pharmaceuticals Plc | JAZZ | 0.00% | $736,654 | 4,052 | -32.4 | $11.6B | Healthcare |
| 22 | Vertex Pharmaceuticals Incorporated | VRTX | 0.00% | $1.0M | 2,206 | 29.2 | $115.6B | Healthcare |
| 23 | United Therapeutics Corporation | UTHR | 0.00% | $1.0M | 1,934 | 18.0 | $23.7B | Healthcare |
| 24 | Amgen Inc. | AMGN | 0.00% | $1.1M | 3,002 | 24.7 | $190.8B | Healthcare |
| 25 | Gilead Sciences, Inc. | GILD | 0.00% | $1.1M | 7,631 | 20.2 | $171.6B | Healthcare |
| 26 | Eli Lilly and Company | LLY | 0.00% | $1.1M | 1,179 | 39.9 | $865.9B | Healthcare |
| 27 | Regeneron Pharmaceuticals, Inc. | REGN | 0.00% | $1.1M | 1,487 | 17.1 | $77.9B | Healthcare |
| 28 | Biogen Inc. | BIIB | 0.00% | $1.2M | 6,413 | 21.5 | $27.8B | Healthcare |
| 29 | Cardinal Health, Inc. | CAH | 0.00% | $1.2M | 5,805 | 29.9 | $49.7B | Healthcare |
| 30 | AbbVie Inc. | ABBV | 0.00% | $1.7M | 8,210 | 87.3 | $366.3B | Healthcare |
| 31 | Pfizer Inc. | PFE | 0.00% | $1.9M | 69,767 | 20.0 | $155.3B | Healthcare |
| 32 | Bristol-Myers Squibb Company | BMY | 0.00% | $2.1M | 36,614 | 17.1 | $120.0B | Healthcare |
| 33 | Johnson & Johnson | JNJ | 0.00% | $2.3M | 9,751 | 21.7 | $578.2B | Healthcare |
| 34 | Merck & Co., Inc. | MRK | 0.00% | $2.3M | 20,535 | 16.3 | $295.1B | Healthcare |
| 35 | Ligand Pharmaceuticals Inc. (Class B) | LGND | 0.00% | $153,026 | 727 | 32.4 | $4.1B | Healthcare |
| 36 | NewAmsterdam Pharma Company N.V. | NAMS | 0.00% | $148,614 | 4,879 | -17.4 | $3.6B | Healthcare |
| 37 | Catalyst Pharmaceuticals, Inc. | CPRX | 0.00% | $130,898 | 5,862 | 13.6 | $2.9B | Healthcare |
| 38 | Supernus Pharmaceuticals, Inc. | SUPN | 0.00% | $127,033 | 2,601 | -74.5 | $2.9B | Healthcare |
| 39 | Insmed Incorporated | INSM | 0.00% | $124,416 | 864 | -24.8 | $32.0B | Healthcare |
| 40 | US Dollar Private | $USD | 0.00% | $86,848 | — | — | — | — |
| 41 | TG Therapeutics, Inc. | TGTX | 0.00% | $121,410 | 3,999 | 10.2 | $5.1B | Healthcare |
| 42 | Prestige Consumer Healthcare Inc. | PBH | 0.00% | $110,210 | 1,835 | 15.7 | $2.9B | Healthcare |
| 43 | ADMA Biologics, Inc. | ADMA | 0.00% | $102,106 | 6,798 | 15.6 | $2.3B | Healthcare |
| 44 | Rhythm Pharmaceuticals, Inc. | RYTM | 0.00% | $102,773 | 1,138 | -28.8 | $5.8B | Healthcare |
| 45 | ACADIA Pharmaceuticals Inc. | ACAD | 0.00% | $93,592 | 4,517 | 9.5 | $3.8B | Healthcare |
| 46 | Alnylam Pharmaceuticals, Inc. | ALNY | 0.00% | $80,886 | 260 | 138.5 | $43.6B | Healthcare |
| 47 | Tempus AI, Inc. (Class A) | TEM | 0.00% | $75,401 | 1,547 | -33.3 | $8.1B | Healthcare |
| 48 | Perrigo Company Plc | PRGO | 0.00% | $61,818 | 6,406 | -0.9 | $1.3B | Healthcare |
| 49 | Corcept Therapeutics Inc. | CORT | 0.00% | $57,357 | 1,683 | 42.4 | $4.3B | Healthcare |
| 50 | Viatris Inc. | VTRS | 0.00% | $1.1M | 81,869 | -4.4 | $15.5B | Healthcare |